These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29514237)

  • 1. Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.
    Frigati L; Archary M; Rabie H; Penazzato M; Ford N
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S147-S151. PubMed ID: 29514237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
    Post FA; Szubert AJ; Prendergast AJ; Johnston V; Lyall H; Fitzgerald F; Musiime V; Musoro G; Chepkorir P; Agutu C; Mallewa J; Rajapakse C; Wilkes H; Hakim J; Mugyenyi P; Walker AS; Gibb DM; Pett SL;
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S132-S139. PubMed ID: 29514234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
    Hakim J; Musiime V; Szubert AJ; Mallewa J; Siika A; Agutu C; Walker S; Pett SL; Bwakura-Dangarembizi M; Lugemwa A; Kaunda S; Karoney M; Musoro G; Kabahenda S; Nathoo K; Maitland K; Griffiths A; Thomason MJ; Kityo C; Mugyenyi P; Prendergast AJ; Walker AS; Gibb DM;
    N Engl J Med; 2017 Jul; 377(3):233-245. PubMed ID: 28723333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.
    Lawn SD; Harries AD; Meintjes G; Getahun H; Havlir DV; Wood R
    AIDS; 2012 Nov; 26(17):2121-33. PubMed ID: 22695302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-related morbidity and mortality in sub-Saharan Africa: opportunities for prevention.
    Lange JM
    AIDS; 1993 Dec; 7(12):1675-6. PubMed ID: 8286080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial.
    Siika A; McCabe L; Bwakura-Dangarembizi M; Kityo C; Mallewa J; Berkley J; Maitland K; Griffiths A; Baleeta K; Mudzingwa S; Abach J; Nathoo K; Thomason MJ; Prendergast AJ; Walker AS; Gibb DM;
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S140-S146. PubMed ID: 29514235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings.
    Lawn SD; Harries AD; Wood R
    Curr Opin HIV AIDS; 2010 Jan; 5(1):18-26. PubMed ID: 20046144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation.
    Harries AD; Lawn SD; Suthar AB; Granich R
    Lancet Infect Dis; 2015 Dec; 15(12):1492-6. PubMed ID: 26515525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.
    Frigati LJ; Kranzer K; Cotton MF; Schaaf HS; Lombard CJ; Zar HJ
    Thorax; 2011 Jun; 66(6):496-501. PubMed ID: 21460373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of cotrimoxazole in people with advanced HIV infection initiating antiretroviral therapy in sub-Saharan Africa.
    Abimbola TO; Marston BJ
    J Acquir Immune Defic Syndr; 2012 May; 60(1):e8-e14. PubMed ID: 22240461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
    Walker AS; Mulenga V; Ford D; Kabamba D; Sinyinza F; Kankasa C; Chintu C; Gibb DM;
    Clin Infect Dis; 2007 May; 44(10):1361-7. PubMed ID: 17443476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections and other causes of death in HIV-infected children in Africa.
    Chakraborty R
    Paediatr Respir Rev; 2004 Jun; 5(2):132-9. PubMed ID: 15135123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa.
    Riitho V; Connon R; Gwela A; Namusanje J; Nhema R; Siika A; Bwakura-Dangarembizi M; Musiime V; Berkley JA; Szubert AJ; Gibb DM; Walker AS; Klein N; Prendergast AJ
    Nat Commun; 2024 Jun; 15(1):5492. PubMed ID: 38944653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges of malnutrition care among HIV-infected children on antiretroviral treatment in Africa.
    Jesson J; Leroy V
    Med Mal Infect; 2015 May; 45(5):149-56. PubMed ID: 25861689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
    PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
    Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIV-associated tuberculosis epidemic--when will we act?
    Harries AD; Zachariah R; Corbett EL; Lawn SD; Santos-Filho ET; Chimzizi R; Harrington M; Maher D; Williams BG; De Cock KM
    Lancet; 2010 May; 375(9729):1906-19. PubMed ID: 20488516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low uptake of antiretroviral therapy after admission with human immunodeficiency virus and tuberculosis in KwaZulu-Natal, South Africa.
    Murphy RA; Sunpath H; Taha B; Kappagoda S; Maphasa KT; Kuritzkes DR; Smeaton L
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):903-8. PubMed ID: 20550776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.